Open Fracture Clinical Trial
Official title:
Antibiotic Prophylaxis for Type II and III Open Fractures: a Retrospective Chart Review
Determine if antibiotic prophylaxis with intravenous cephalosporin and aminoglycoside in patients with Type II and II open fractures is safe and effective.
1. Determine the safety and efficacy of antibiotic prophylaxis in type II and II open
fractures when using IV Cephalosporin and aminoglycoside.
2. Identify the incidence of acute kidney injury.
3. Identify the type and number of associated infections
4. Identify the antibiotic resistance profile noted
5. Identify any secondary infections at sites other than the fracture site
;
Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01496014 -
Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage
|
||
| Recruiting |
NCT03765567 -
Placement of Antibiotic Powder in Wounds During the Emergency Room
|
Phase 4 | |
| Recruiting |
NCT06033534 -
Evaluation of STIMULAN Device and AI Model in Preventing Fracture Infections
|
N/A | |
| Completed |
NCT04418882 -
Septic Management and Outcome of Open Fracture
|
||
| Recruiting |
NCT05785182 -
OCT in Open Fracture and Infected Fracture
|
||
| Completed |
NCT00299052 -
Efficacy of DBM on Fractures of the Shinbone (Tibia)
|
Phase 4 | |
| Terminated |
NCT03560232 -
Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens
|
Phase 4 |